|
Co-Chairs
Keith Brownlie
Ernst & Young
Manya Deehr
Eurand
BioNJ
Debbie Hart
President
Pennsylvania Bio
Dennis M. "Mickey" Flynn
President
Steering Committee
Laura Alexandre
Pennsylvania Bio
Gwilym Attwell
Fish & Richardson P.C.
Stephanie Baldwin
Antares Pharma
Karla Beckner White
Pennsylvania Bio
Ali Bolat
Unigene Laboratories
Michael Brown
Fisher Scientific
Katie Clarke
Pennsylvania Bio
Robert Dayton
Delaware Bioscience Association
Patricia Dunphy
BioNJ
Kate Eby Moore
Wyeth
Brian Gill
Celgene Corporation
Uli Grau, Ph.D.
Lux Biosciences
Kristin Hassan
BioNJ
Jeffrey Hendrey
PricewaterhouseCoopers
Thomas Hess
Yaupon Therapeutics Inc.
Jane Hollingsworth
NuPathe Inc.
Stephen Jannetta
Morgan, Lewis & Bockius LLP
Rajiv Khosla
Biovail Pharmaceuticals
Tom Koncsics
KPMG LLP
Reid Leonard, Ph.D.
Merck & Co., Inc.
Jeffrey Libson
Pepper Hamilton LLP
John Manzetti
Pittsburgh Life Sciences Greenhouse
James Marino
Dechert LLP
David Miller
GlaxoSmithKline
Christopher Molineaux
Centocor, Inc./Johnson & Johnson
Gerard Norton
Fox Rothschild LLP
Bill O'Donnell
BioNJ
Kathleen Otto
BioNJ
Anthony Pagano
Genmab
Robert Pietrusko, Pharm.D.
ViroPharma Incorporated
Steven Projan, Ph.D.
Novartis Institutes for Biomedical Research
Jason Rubin
The Redstone Group
Christopher Schaber, Ph.D.
DOR BioPharma, Inc.
Judith Sheft
New Jersey Institute of Technology
Marie Stewart
Pennsylvania Bio
Amber van Niekerk
Pennsylvania Bio
Bob Ward
NPS Pharmaceuticals
Sheryl Williams
Cephalon, Inc.
Dennis Willson
Cytokine PharmaSciences, Inc.
Chris Yochim
AstraZeneca
|